A Phase 1b Study Evaluating the Safety, Tolerability, Pharmacokinetics and Efficacy of Oprozomib in Combination With Pomalidomide and Dexamethasone in Subjects With Relapsed or Refractory Multiple Myeloma

Type of Cancer
Multiple Myeloma

Site
Bethesda

Sponsor
(Oprozomib) 20160104

To Learn More Call
201-510-0910